CardieX Limited (CDX.AX)
AUD 0.09
(-14.55%)
AUD 0.09
(-14.55%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 10.9 Million AUD | 136.86% |
| 2023 | 4.6 Million AUD | 13.21% |
| 2022 | 4.06 Million AUD | -18.68% |
| 2021 | 5 Million AUD | 16.51% |
| 2020 | 4.29 Million AUD | 9.87% |
| 2019 | 3.9 Million AUD | -2.47% |
| 2018 | 4 Million AUD | -7.42% |
| 2017 | 4.32 Million AUD | -13.79% |
| 2016 | 5.01 Million AUD | -8.2% |
| 2015 | 5.46 Million AUD | 8.2% |
| 2014 | 5.05 Million AUD | -44.2% |
| 2013 | 9.05 Million AUD | 40.58% |
| 2012 | 6.44 Million AUD | -13.63% |
| 2011 | 7.45 Million AUD | -18.92% |
| 2010 | 9.19 Million AUD | -17.94% |
| 2009 | 11.2 Million AUD | 73.77% |
| 2008 | 6.45 Million AUD | 32.35% |
| 2007 | 4.87 Million AUD | 46.19% |
| 2006 | 3.33 Million AUD | 7.34% |
| 2005 | 3.1 Million AUD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 1.21 Million AUD | -87.16% |
| 2024 Q4 | 1.21 Million AUD | 0.0% |
| 2024 Q2 | 9.47 Million AUD | 82.47% |
| 2024 FY | 10.9 Million AUD | 136.86% |
| 2024 Q1 | 5.19 Million AUD | 63.97% |
| 2023 FY | 4.6 Million AUD | 13.21% |
| 2023 Q4 | 3.16 Million AUD | 67.51% |
| 2023 Q2 | 1.43 Million AUD | 50.52% |
| 2023 Q1 | 955.92 Thousand AUD | -51.59% |
| 2023 Q3 | 1.88 Million AUD | 31.33% |
| 2022 FY | 4.06 Million AUD | -18.68% |
| 2022 Q4 | 1.97 Million AUD | 69.07% |
| 2022 Q3 | 1.16 Million AUD | -44.18% |
| 2022 Q2 | 2.09 Million AUD | 74.2% |
| 2022 Q1 | 1.2 Million AUD | -51.12% |
| 2021 Q2 | 2.54 Million AUD | 79.36% |
| 2021 Q1 | 1.41 Million AUD | -34.0% |
| 2021 Q4 | 2.45 Million AUD | 81.51% |
| 2021 Q3 | 1.35 Million AUD | -46.79% |
| 2021 FY | 5 Million AUD | 16.51% |
| 2020 Q2 | 2.14 Million AUD | 78.26% |
| 2020 FY | 4.29 Million AUD | 9.87% |
| 2020 Q4 | 2.14 Million AUD | 81.08% |
| 2020 Q3 | 1.18 Million AUD | -44.63% |
| 2020 Q1 | 1.2 Million AUD | -37.35% |
| 2019 Q2 | 1.18 Million AUD | -0.0% |
| 2019 Q4 | 1.91 Million AUD | 62.65% |
| 2019 FY | 3.9 Million AUD | -2.47% |
| 2019 Q1 | 1.18 Million AUD | 16.51% |
| 2019 Q3 | 1.17 Million AUD | -0.8% |
| 2018 Q4 | 1.02 Million AUD | 0.0% |
| 2018 Q3 | 1.02 Million AUD | -14.3% |
| 2018 FY | 4 Million AUD | -7.42% |
| 2018 Q2 | 1.19 Million AUD | 0.0% |
| 2018 Q1 | 1.19 Million AUD | -19.55% |
| 2017 FY | 4.32 Million AUD | -13.79% |
| 2017 Q2 | 919.48 Thousand AUD | -0.0% |
| 2017 Q1 | 919.48 Thousand AUD | -44.79% |
| 2017 Q4 | 1.48 Million AUD | 0.0% |
| 2017 Q3 | 1.48 Million AUD | 61.04% |
| 2016 Q3 | 1.66 Million AUD | 97.24% |
| 2016 Q4 | 1.66 Million AUD | 0.0% |
| 2016 Q2 | 844.32 Thousand AUD | -0.0% |
| 2016 Q1 | 844.32 Thousand AUD | -35.28% |
| 2016 FY | 5.01 Million AUD | -8.2% |
| 2015 FY | 5.46 Million AUD | 8.2% |
| 2015 Q4 | 1.3 Million AUD | 0.0% |
| 2015 Q3 | 1.3 Million AUD | -8.72% |
| 2015 Q2 | 1.42 Million AUD | 0.0% |
| 2015 Q1 | 1.42 Million AUD | 20.15% |
| 2014 Q4 | 1.18 Million AUD | 0.0% |
| 2014 Q1 | 1.33 Million AUD | -26.26% |
| 2014 FY | 5.05 Million AUD | -44.2% |
| 2014 Q2 | 1.33 Million AUD | -0.0% |
| 2014 Q3 | 1.18 Million AUD | -11.03% |
| 2013 Q3 | 1.81 Million AUD | -33.21% |
| 2013 Q2 | 2.71 Million AUD | -0.0% |
| 2013 Q4 | 1.81 Million AUD | 0.0% |
| 2013 FY | 9.05 Million AUD | 40.58% |
| 2013 Q1 | 2.71 Million AUD | 68.57% |
| 2012 Q2 | 1.61 Million AUD | -13.63% |
| 2012 Q4 | 1.61 Million AUD | 0.0% |
| 2012 Q3 | 1.61 Million AUD | 0.0% |
| 2012 Q1 | 1.86 Million AUD | 0.0% |
| 2012 FY | 6.44 Million AUD | -13.63% |
| 2011 Q1 | 2.29 Million AUD | 0.0% |
| 2011 Q4 | 1.86 Million AUD | 0.0% |
| 2011 FY | 7.45 Million AUD | -18.92% |
| 2011 Q3 | 1.86 Million AUD | 0.0% |
| 2011 Q2 | 1.86 Million AUD | -18.92% |
| 2010 Q2 | 2.29 Million AUD | -17.94% |
| 2010 Q3 | 2.29 Million AUD | 0.0% |
| 2010 Q1 | 2.8 Million AUD | 0.0% |
| 2010 FY | 9.19 Million AUD | -17.94% |
| 2010 Q4 | 2.29 Million AUD | 0.0% |
| 2009 Q2 | 2.8 Million AUD | 73.77% |
| 2009 Q4 | 2.8 Million AUD | 0.0% |
| 2009 Q1 | 1.61 Million AUD | 0.0% |
| 2009 Q3 | 2.8 Million AUD | 0.0% |
| 2009 FY | 11.2 Million AUD | 73.77% |
| 2008 Q1 | 1.21 Million AUD | 0.0% |
| 2008 Q2 | 1.61 Million AUD | 32.35% |
| 2008 Q3 | 1.61 Million AUD | 0.0% |
| 2008 FY | 6.45 Million AUD | 32.35% |
| 2008 Q4 | 1.61 Million AUD | 0.0% |
| 2007 Q2 | 1.21 Million AUD | 46.19% |
| 2007 Q3 | 1.21 Million AUD | 0.0% |
| 2007 Q4 | 1.21 Million AUD | 0.0% |
| 2007 FY | 4.87 Million AUD | 46.19% |
| 2007 Q1 | 833.5 Thousand AUD | 0.0% |
| 2006 Q3 | 833.5 Thousand AUD | 0.0% |
| 2006 Q1 | 776.5 Thousand AUD | 0.0% |
| 2006 FY | 3.33 Million AUD | 7.34% |
| 2006 Q2 | 833.5 Thousand AUD | 7.34% |
| 2006 Q4 | 833.5 Thousand AUD | 0.0% |
| 2005 Q4 | 776.5 Thousand AUD | 0.0% |
| 2005 Q2 | 776.5 Thousand AUD | 0.0% |
| 2005 FY | 3.1 Million AUD | 0.0% |
| 2005 Q3 | 776.5 Thousand AUD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| 4DMedical Limited | 3.75 Million AUD | -190.487% |
| Adherium Limited | 840.98 Thousand AUD | -1196.774% |
| Aroa Biosurgery Limited | 63.35 Million AUD | 82.787% |
| Atomo Diagnostics Limited | 4.08 Million AUD | -166.868% |
| Anteris Technologies Ltd | 4.11 Million AUD | -165.274% |
| Control Bionics Limited | 5.12 Million AUD | -112.714% |
| Compumedics Limited | 49.71 Million AUD | 78.065% |
| Cochlear Limited | 2.25 Billion AUD | 99.517% |
| CleanSpace Holdings Limited | 15.72 Million AUD | 30.633% |
| Cyclopharm Limited | 27.13 Million AUD | 59.816% |
| EMVision Medical Devices Ltd | 11.21 Million AUD | 2.795% |
| Nova Eye Medical Limited | 23.32 Million AUD | 53.245% |
| HeraMED Limited | 402.89 Thousand AUD | -2606.805% |
| Imricor Medical Systems, Inc. | 615.56 Thousand AUD | -1671.638% |
| ImpediMed Limited | 10.31 Million AUD | -5.685% |
| InhaleRx Limited | 1.2 Million AUD | -805.749% |
| LBT Innovations Limited | 1.25 Million AUD | -768.283% |
| Micro-X Limited | 15.22 Million AUD | 28.356% |
| Neurotech International Limited | 1963.00 AUD | -555459.654% |
| OncoSil Medical Limited | 1.56 Million AUD | -596.675% |
| PolyNovo Limited | 103.19 Million AUD | 89.432% |
| Respiri Limited | 456.91 Thousand AUD | -2286.803% |
| SomnoMed Limited | 91.65 Million AUD | 88.101% |
| Universal Biosensors, Inc. | 6.63 Million AUD | -64.419% |
| Uscom Limited | 3.72 Million AUD | -192.624% |
| Visioneering Technologies, Inc. | 8.67 Million AUD | -25.786% |